KPTI · Company research
Karyopharm Therapeutics Inc. (KPTI): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
15records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Why Is KPTI Stock Down 69% After-Hours Today? - Stocktwits | Why Is KPTI Stock Down 69% After-Hours Today? Stocktwits | View source ↗ | Stocktwits | Oct 11, 2026 | neutral | 0 | 0.6 |
| MU, SNDK, WDC, SKHY Stock Jump After-Hours — Memory Chipmakers Soar After Amazon, Apple Management Flag Soaring Costs, Supply Crunch - Stocktwits | MU, SNDK, WDC, SKHY Stock Jump After-Hours — Memory Chipmakers Soar After Amazon, Apple Management Flag Soaring Costs, Supply Crunch Stocktwits | View source ↗ | Stocktwits | Oct 11, 2026 | neutral | 0 | 0.6 |
| Two Acorn funds account for one manager’s reported stake in Karyopharm (KPTI). - Stock Titan | Two Acorn funds account for one manager’s reported stake in Karyopharm (KPTI). Stock Titan | View source ↗ | Stock Titan | Oct 8, 2026 | neutral | 0 | 0.6 |
| KPTI News | KARYOPHARM THERAPEUTICS INC (NASDAQ:KPTI) - ChartMill | KPTI News | KARYOPHARM THERAPEUTICS INC (NASDAQ:KPTI) ChartMill | View source ↗ | ChartMill | Oct 3, 2026 | neutral | 0 | 0.6 |
| A tax-related sale: Karyopharm (KPTI) accounting chief sells 378 shares at $1.19 each. - Stock Titan | A tax-related sale: Karyopharm (KPTI) accounting chief sells 378 shares at $1.19 each. Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| A new Karyopharm hire gets 333 stock units, vesting over 3 years if they stay. - Stock Titan | A new Karyopharm hire gets 333 stock units, vesting over 3 years if they stay. Stock Titan | View source ↗ | Stock Titan | Oct 1, 2026 | neutral | 0 | 0.6 |
| $KPTI stock is down 21% today. Here's what we see in our data. - Quiver Quantitative | $KPTI stock is down 21% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 29, 2026 | neutral | 0 | 0.6 |
| $KPTI stock is down 21% today. Here's what we see in our data. - Quiver Quantitative | $KPTI stock is down 21% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 29, 2026 | neutral | 0 | 0.6 |
| Karyopharm Therapeutics (KPTI) Stock Fair Value Falls After Split Analyst Views On Trial Updates - Yahoo Finance | Karyopharm Therapeutics (KPTI) Stock Fair Value Falls After Split Analyst Views On Trial Updates Yahoo Finance | View source ↗ | Yahoo Finance | Sep 4, 2026 | neutral | 0 | 0.6 |
| Karyopharm Therapeutics (KPTI) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance | Karyopharm Therapeutics (KPTI) Reports Q2 Loss, Beats Revenue Estimates Yahoo Finance | View source ↗ | Yahoo Finance | Aug 13, 2026 | neutral | 0 | 0.6 |
| KPTI Stock Crashes As Trial Fails And Legal Risk Mounts - Timothy Sykes | KPTI Stock Crashes As Trial Fails And Legal Risk Mounts Timothy Sykes | View source ↗ | Timothy Sykes | Jul 31, 2026 | neutral | 0 | 0.6 |
| Why Is KPTI Stock Down 69% After-Hours Today? - TradingView | Why Is KPTI Stock Down 69% After-Hours Today? TradingView | View source ↗ | TradingView | Jul 30, 2026 | neutral | 0 | 0.6 |
| Karyopharm Therapeutics (KPTI) Stock Sees Split Analyst Revisions After Phase 3 Trial Update - Yahoo Finance | Karyopharm Therapeutics (KPTI) Stock Sees Split Analyst Revisions After Phase 3 Trial Update Yahoo Finance | View source ↗ | Yahoo Finance | Jun 25, 2026 | neutral | 0 | 0.6 |
| Karyopharm Therapeutics (KPTI) Stock Jumps 6.9%: Will It Continue to Soar? - Yahoo Finance | Karyopharm Therapeutics (KPTI) Stock Jumps 6.9%: Will It Continue to Soar? Yahoo Finance | View source ↗ | Yahoo Finance | Mar 27, 2026 | neutral | 0 | 0.6 |
| Karyopharm Announces $30 Million Private Placement with RA Capital - PR Newswire | Karyopharm Announces $30 Million Private Placement with RA Capital PR Newswire | View source ↗ | PR Newswire | Mar 24, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.